pyrrolidin-3-yl-methanesulfonic acid has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abubakar, S; Busaidi, AA; Jain, A; Riyami, KA; Usmani, S | 1 |
| Esmail, A; Marafi, F; Usmani, S | 1 |
2 other study(ies) available for pyrrolidin-3-yl-methanesulfonic acid and Cancer of Prostate
| Article | Year |
|---|---|
Tumour sink effect on 68Ga-PMSA PET/CT: A case of diffuse metastatic disease of prostate cancer.
Topics: Humans; Male; Middle Aged; Neoplasms, Second Primary; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2023 |
Prostate-Specific Membrane Antigen Expression in Metastatic Angiosarcoma Detected on 18F-PMSA PET/CT: A New Potential Prognostic Marker.
Topics: Gallium Radioisotopes; Hemangiosarcoma; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Prostate; Prostatic Neoplasms; Pyrrolidines | 2022 |